Omicron C. auris Header

Coronavirus Omicron Variant

Coronavirus remains at the forefront of infection prevention with its multiple variants. The newest variant, Omicron (B.1.1.529), has been designated by the WHO as a variant of concern on November 26, 2021. Omicron has several mutations, spreads easily, and demonstrates different symptoms than the Delta variant.

In addition, Omicron has been shown to have an increased risk of reinfection compared to other highly transmissible variants. This indicates that people who contracted COVID and recovered could be more subject to catching it again with this variant.

Discovered in South Africa, the number of people testing positive for the Omicron variant has risen in South African regions. This growing number of cases suggests the variant is spreading at a rapid pace. Along with the rising case numbers, South Africa is currently experiencing an increase in hospitalization due to the sudden influx of coronavirus patients. Just recently we found out that this variant has landed in North America. As we continue to learn more about Omicron, we know that disinfection protocols are important for all businesses to remain operational in the face of an outbreak.

Candida auris - Healthcare-Associated Infections

Just as coronavirus is an emerging pathogen; funguses also continue to emerge, posing a serious global health threat. Candida auris (C. auris) is one such fungus. Despite being first identified in 2009, C. auris remains an emerging pathogen/fungus due to the increasing number of infections throughout numerous countries across the globe. Often found in healthcare facilities and nursing homes as part of healthcare-associated infections (HAIs), C. auris is a type of yeast that causes severe illness, entering the bloodstream and spreading throughout the body to cause serious infections.

According to the CDC, C. auris is cause for concern for three main reasons:

  1. It is often multidrug-resistant.
  2. It is difficult to identify and can be misidentified, leading to managing diagnosis improperly.
  3. It causes outbreaks in healthcare settings.

It is very important to identify C. auris quickly, taking special precautions to stop its spread. One such precaution includes adding a trusted, premium disinfection to your cleaning protocols.

SteraMist Disinfection Is The Solution

EPA Registered Combination

Adding disinfection that can combat these rapidly spreading pathogens is critical for businesses to remain open. EPA-registered as an equipment and solution combination, featuring a quick 5-second kill with widespread coverage, and leaving no residues to wipe or rinse, SteraMist disinfection technology has many incredible advantages over competitors.

EPA Reg. 90150-2 Binary Ionization Technology (BIT) Solution 

CONTACT US TODAY
close slider
Translate »